Ingredient Optimized Announces Series A Fundraise To Invoke A Movement In The Nutrition Industry With Biotechnology-Backed Protein
Ingredient Optimized Announces Series A Fundraise To Invoke A Movement In The Nutrition Industry With Biotechnology-Backed Protein
11/04/21, 9:00 AM
Round Type
series a
Ingredient Optimized (io), a patent-pending biotechnology company dedicated to improving the taste and quality of protein powder, announced today that it has raised a Series A financing round led by Continental Grain. This investment follows several years of clinical research and development, including 10 human clinical trials that further validate io's technology as being able to improve health outcomes through superior protein absorption by the body. This financing will help io drive awareness around the importance of protein absorption and bring its technology and products to consumers at scale. Brian Loeb of Continental Grain will be taking a board seat at io
Company Info
Additional Info
Ingredient Optimized is a biotechnology company focused on improving the quality of protein and overall nutrition through their Ingredient Optimized technology. When their io isolate is a component ingredient, protein products are able to deliver superior protein absorption by the body, reduced stomach discomfort, and improved taste. Backed by scientific research and clinical trials, the io technology is able to improve health outcomes for the protein-deficient elderly and bodybuilders alike.
Follow Ingredient Optimized on Twitter, Instagram, and Facebook.